569 results on '"M. Bandini"'
Search Results
2. Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function
3. Pathological features and predictors of oncologic outcomes in patients with small renal masses
4. Focal therapy for prostate cancer: do apical lesions correlate with worse outcomes?
5. Changing patterns and predictors of salvage radiation therapy use over time in patients treated for post-prostatectomy biochemical recurrence: a trend analysis over a 20-year period from a multi institutional series
6. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance. results from a single institution series
7. The relative drop of PSA values after androgen deprivation therapy is a useful parameter to select the best candidate for cytoreductive radical prostatectomy among patients with oligometastatic prostate cancer: an external validation study
8. Impact of histological variants in node positive patients treated with radical cystectomy for bladder cancer
9. No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: interim results from the PURE01 study
10. Limited vs extended lymph node dissection in T1G3 bladder cancer patients treated with radical cystectomy: is this group responsible for the negative results of the LEA trial?
11. Incongruence between turb and radical cystectomy findings in terms of histological variant identification: analysis of all potential clinical risk factors
12. Development of a risk calculator of recurrence in inguinal lymph-node metastatic (ILNM) patients with surgically-resected penile squamous-cell carcinoma (PSCC)
13. How can we increase the positive predictive value of PIRADS 4 and 5 lesions at mp-MRI? Development of a novel prediction tool relying on a large, multi-institutional series
14. When is mp-MRI reliable in predicting extra-prostatic extension in prostate cancer patients treated with radical prostatectomy? Results from a large, multi-institutional series
15. No-response at mpMRI after neoadjuvant pembrolizumab is a proxy of adverse pathological and oncological outcomes in patients treated with radical cystectomy: Interim results from the PURE01 study
16. Incongruence between TURB and radical cystectomy findings in terms of histological variant identification: Analysis of all potential clinical risk factors
17. Outcome of non-responders to neoadjuvant immunotherapy compared to cisplatin-based chemotherapy before radical cystectomy in muscle-invasive bladder cancer
18. Prognostic value of high PIRADS score lesions at mp-MRI of the prostate in men with low risk prostate cancer managed with active surveillance: Results from a single institution series
19. Interim results of PEANUT: An open-label, single-arm, phase 2 study evaluating pembrolizumab plus nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)
20. Regression-tree analysis for identifying the best candidates to neoadjuvant chemotherapy in patients with clinical node-positive penile squamous-cell carcinoma
21. Land reform in Italy
22. Sei anni di riforma fondiaria in Italia.
23. Osservazioni sull'agricoltura europea e sul contributo dell'Italia.
24. Sulla questione meridionale: industrializzazione o 'preindustrializzazione'?
25. La riforma fondiaria in Italia
26. Six years of Italian land reform
27. Neurodevelopmental Outcomes of Extremely Low Birth Weight Survivors in Johannesburg, South Africa
28. Introduction of an innovative holistic integrated system for the distinctive valorisation of 'premium quality' Italian northern district processing tomato
29. Performance Evaluation of PVC-Free Metal Caps from the Point of View of Suitability for Food Contact and Tightness of the Packaging
30. Chemotherapy vs. immunotherapy as neoadjuvant therapies in cisplatin-eligible patients undergoing radical cystectomy for muscle invasive bladder cancer
31. Does prostate cancer family history have an impact on active surveillance adherence in men with low- or favourable intermediate risk disease?
32. New size cut-off proposed by EAU Renal Cancer Working group better identifies patients who can benefit from local tumor ablation
33. P293 MULTI–DIMENSIONAL EVALUATION IN PATIENTS WITH AORTIC STENOSIS CANDIDATE FOR CARDIAC SURGERY
34. Epidemiology, risk factors and outcomes associated with candidaemia in very low birth weight infants at a tertiary South African Hospital over a 7-year period (2013–2019)
35. The impact of histology and type of energy used on oncological outcomes after local tumor ablation of small renal masses
36. 1738P Three-year follow-up update and survival outcomes of the PURE-01 study
37. On the efficiency of machine learning for fatigue assessment of post-processed additively manufactured AlSi10Mg
38. Effect of heat treatment temperature and turning residual stresses on the plain and notch fatigue strength of Ti-6Al-4V additively manufactured via laser powder bed fusion
39. The optimal management after ventral onlay buccal mucosa graft urethroplasty failure
40. A novel model Integrating clinical, mp-MRI, and epigenomic features to predict lymph node invasion in prostate cancer patients undergoing radical prostatectomy and pelvic lymph node dissection
41. Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging–Reporting and Data System (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis of the PURE-01 cohort
42. Therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy should not be discontinued in low- and middle-income countries
43. OP20 Three year-survival outcomes after neoadjuvant pembrolizumab and radical cystectomy: Final results from the PURE-01 study
44. Delaying post-operative radiation therapy after radical prostatectomy is associated with increased functional outcomes: results from a large single, referral center series
45. Perioperative complications after radical cystectomy for bladder cancer: an international multicenter collaboration
46. Three year-survival outcomes after neoadjuvant pembrolizumab and radical cystectomy: final results from the pure-01 study
47. A more extended pelvic lymph node dissection decreases recurrence rates in selected prostate cancer patients undergoing radical prostatectomy
48. Perc-score as a nephrometry scoring system in percutaneous tumour ablation: comparison with renal, mrenal, padua and spare in a multi-centre series
49. Clinical Characteristics, Maternal and Neonatal Outcomes of COVID-19 Positive Pregnant Mothers at a Tertiary Hospital in Johannesburg, South Africa
50. Oncologic surveillance for variant histology upper tract urothelial carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.